• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

亨廷顿舞蹈病基因敲入小鼠的等位基因系列揭示了表达不相关。

Allelic series of Huntington's disease knock-in mice reveals expression discorrelates.

作者信息

Kumar Ashish, Zhang Jennifer, Tallaksen-Greene Sara, Crowley Michael R, Crossman David K, Morton A Jennifer, Van Groen Thomas, Kadish Inga, Albin Roger L, Lesort Mathieu, Detloff Peter J

机构信息

Department of Cell, Developmental and Integrative Biology.

Department of Biochemistry and Molecular Genetics.

出版信息

Hum Mol Genet. 2016 Apr 15;25(8):1619-36. doi: 10.1093/hmg/ddw040. Epub 2016 Feb 14.

DOI:10.1093/hmg/ddw040
PMID:26908599
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4805312/
Abstract

Identifying molecular drivers of pathology provides potential therapeutic targets. Differentiating between drivers and coincidental molecular alterations presents a major challenge. Variation unrelated to pathology further complicates transcriptomic, proteomic and metabolomic studies which measure large numbers of individual molecules. To overcome these challenges towards the goal of determining drivers of Huntington's disease (HD), we generated an allelic series of HD knock-in mice with graded levels of phenotypic severity for comparison with molecular alterations. RNA-sequencing analysis of this series reveals high numbers of transcripts with level alterations that do not correlate with phenotypic severity. These discorrelated molecular changes are unlikely to be drivers of pathology allowing an exclusion-based strategy to provide a short list of driver candidates. Further analysis of the data shows that a majority of transcript level changes in HD knock-in mice involve alteration of the rate of mRNA processing and/or degradation rather than solely being due to alteration of transcription rate. The overall strategy described can be applied to assess the influence of any molecular change on pathology for diseases where different mutations cause graded phenotypic severity.

摘要

识别病理学的分子驱动因素可提供潜在的治疗靶点。区分驱动因素和偶然的分子改变是一项重大挑战。与病理学无关的变异使测量大量单个分子的转录组学、蛋白质组学和代谢组学研究更加复杂。为了克服这些挑战以实现确定亨廷顿舞蹈病(HD)驱动因素的目标,我们构建了一系列具有不同程度表型严重程度的HD基因敲入小鼠等位基因系列,以便与分子改变进行比较。对该系列小鼠进行RNA测序分析发现,大量转录本水平发生改变,但这些改变与表型严重程度无关。这些不相关的分子变化不太可能是病理学的驱动因素,因此可以采用基于排除法的策略来列出候选驱动因素的简短清单。对数据的进一步分析表明,HD基因敲入小鼠中大多数转录本水平的变化涉及mRNA加工和/或降解速率的改变,而不仅仅是由于转录速率的改变。所描述的总体策略可应用于评估任何分子变化对不同突变导致表型严重程度分级的疾病病理学的影响。

相似文献

1
Allelic series of Huntington's disease knock-in mice reveals expression discorrelates.亨廷顿舞蹈病基因敲入小鼠的等位基因系列揭示了表达不相关。
Hum Mol Genet. 2016 Apr 15;25(8):1619-36. doi: 10.1093/hmg/ddw040. Epub 2016 Feb 14.
2
Mass Spectrometry Analysis of Wild-Type and Knock-in Q140/Q140 Huntington's Disease Mouse Brains Reveals Changes in Glycerophospholipids Including Alterations in Phosphatidic Acid and Lyso-Phosphatidic Acid.野生型和敲入Q140/Q140亨廷顿舞蹈病小鼠大脑的质谱分析揭示了甘油磷脂的变化,包括磷脂酸和溶血磷脂酸的改变。
J Huntingtons Dis. 2015;4(2):187-201. doi: 10.3233/JHD-150149.
3
Transgenic animal models for study of the pathogenesis of Huntington's disease and therapy.用于研究亨廷顿舞蹈病发病机制和治疗的转基因动物模型。
Drug Des Devel Ther. 2015 Apr 15;9:2179-88. doi: 10.2147/DDDT.S58470. eCollection 2015.
4
Differential effects of delayed aging on phenotype and striatal pathology in a murine model of Huntington disease.延迟衰老对亨廷顿病小鼠模型表型和纹状体病理学的影响差异。
J Neurosci. 2014 Nov 19;34(47):15658-68. doi: 10.1523/JNEUROSCI.1830-14.2014.
5
Wheel running and environmental enrichment differentially modify exon-specific BDNF expression in the hippocampus of wild-type and pre-motor symptomatic male and female Huntington's disease mice.轮跑和环境丰富以不同的方式改变了野生型和运动前症状雄性和雌性亨廷顿病小鼠海马体中特定外显子的 BDNF 表达。
Hippocampus. 2010 May;20(5):621-36. doi: 10.1002/hipo.20658.
6
Micro RNA-214 contributes to proteasome independent downregulation of beta catenin in Huntington's disease knock-in striatal cell model STHdhQ111/Q111.微小RNA-214在亨廷顿舞蹈病基因敲入纹状体细胞模型STHdhQ111/Q111中促成β-连环蛋白的蛋白酶体非依赖性下调。
Biochem Biophys Res Commun. 2015 Apr 10;459(3):509-14. doi: 10.1016/j.bbrc.2015.02.137. Epub 2015 Mar 4.
7
Early white matter abnormalities, progressive brain pathology and motor deficits in a novel knock-in mouse model of Huntington's disease.亨廷顿舞蹈病新型基因敲入小鼠模型中的早期白质异常、进行性脑病理学改变及运动功能障碍
Hum Mol Genet. 2015 May 1;24(9):2508-27. doi: 10.1093/hmg/ddv016. Epub 2015 Jan 21.
8
Gene expression in Huntington's disease skeletal muscle: a potential biomarker.亨廷顿舞蹈症骨骼肌中的基因表达:一种潜在的生物标志物。
Hum Mol Genet. 2005 Jul 1;14(13):1863-76. doi: 10.1093/hmg/ddi192. Epub 2005 May 11.
9
Reduced expression of the TrkB receptor in Huntington's disease mouse models and in human brain.在亨廷顿舞蹈症小鼠模型和人类大脑中,TrkB受体的表达降低。
Eur J Neurosci. 2006 Feb;23(3):649-58. doi: 10.1111/j.1460-9568.2006.04590.x.
10
Characterization of Behavioral, Neuropathological, Brain Metabolic and Key Molecular Changes in zQ175 Knock-In Mouse Model of Huntington's Disease.亨廷顿舞蹈病zQ175基因敲入小鼠模型的行为、神经病理学、脑代谢及关键分子变化特征
PLoS One. 2016 Feb 9;11(2):e0148839. doi: 10.1371/journal.pone.0148839. eCollection 2016.

引用本文的文献

1
Advances in Stem Cell Therapy for Huntington's Disease: A Comprehensive Literature Review.亨廷顿舞蹈症干细胞治疗进展:一项全面的文献综述
Cells. 2025 Jan 3;14(1):42. doi: 10.3390/cells14010042.
2
HSF1 and Its Role in Huntington's Disease Pathology.HSF1 及其在亨廷顿病病理学中的作用。
Adv Exp Med Biol. 2023;1410:35-95. doi: 10.1007/5584_2022_742.
3
Modelling the Human Blood-Brain Barrier in Huntington Disease.在亨廷顿病中模拟血脑屏障。
Int J Mol Sci. 2022 Jul 15;23(14):7813. doi: 10.3390/ijms23147813.
4
Uninterrupted CAG repeat drives striatum-selective transcriptionopathy and nuclear pathogenesis in human Huntingtin BAC mice.不间断的 CAG 重复驱动人类亨廷顿 BAC 小鼠纹状体选择性转录病和核发病。
Neuron. 2022 Apr 6;110(7):1173-1192.e7. doi: 10.1016/j.neuron.2022.01.006. Epub 2022 Feb 2.
5
Huntington's disease: nearly four decades of human molecular genetics.亨廷顿病:近四十年的人类分子遗传学研究。
Hum Mol Genet. 2021 Oct 1;30(R2):R254-R263. doi: 10.1093/hmg/ddab170.
6
What is the Pathogenic CAG Expansion Length in Huntington's Disease?亨廷顿病的致病 CAG 扩增长度是多少?
J Huntingtons Dis. 2021;10(1):175-202. doi: 10.3233/JHD-200445.
7
A Role for PGC-1α in Transcription and Excitability of Neocortical and Hippocampal Excitatory Neurons.PGC-1α 在新皮层和海马兴奋性神经元转录和兴奋性中的作用。
Neuroscience. 2020 May 21;435:73-94. doi: 10.1016/j.neuroscience.2020.03.036. Epub 2020 Mar 25.
8
Sex-dependent impaired locomotion and motor coordination in the HdhQ200/200 mouse model of Huntington's Disease.亨廷顿病 HdhQ200/200 小鼠模型中性别依赖性运动障碍和运动协调受损。
Neurobiol Dis. 2019 Dec;132:104607. doi: 10.1016/j.nbd.2019.104607. Epub 2019 Sep 6.
9
Cell-Specific Deletion of PGC-1α from Medium Spiny Neurons Causes Transcriptional Alterations and Age-Related Motor Impairment.中脑多巴胺能神经元中 PGC-1α 的细胞特异性缺失导致转录改变和与年龄相关的运动障碍。
J Neurosci. 2018 Mar 28;38(13):3273-3286. doi: 10.1523/JNEUROSCI.0848-17.2018. Epub 2018 Feb 28.
10
Progress in developing transgenic monkey model for Huntington's disease.亨廷顿病转基因猴模型的研究进展。
J Neural Transm (Vienna). 2018 Mar;125(3):401-417. doi: 10.1007/s00702-017-1803-y. Epub 2017 Nov 10.

本文引用的文献

1
Early white matter abnormalities, progressive brain pathology and motor deficits in a novel knock-in mouse model of Huntington's disease.亨廷顿舞蹈病新型基因敲入小鼠模型中的早期白质异常、进行性脑病理学改变及运动功能障碍
Hum Mol Genet. 2015 May 1;24(9):2508-27. doi: 10.1093/hmg/ddv016. Epub 2015 Jan 21.
2
A common gene expression signature in Huntington's disease patient brain regions.亨廷顿舞蹈病患者脑区中的一种常见基因表达特征。
BMC Med Genomics. 2014 Oct 30;7:60. doi: 10.1186/s12920-014-0060-2.
3
Animal models of Huntington's disease for translation to the clinic: best practices.用于转化至临床的亨廷顿舞蹈病动物模型:最佳实践
Mov Disord. 2014 Sep 15;29(11):1375-90. doi: 10.1002/mds.26006.
4
Spatial distribution of insulin-like growth factor binding protein-2 following hypoxic-ischemic injury.缺氧缺血性损伤后胰岛素样生长因子结合蛋白-2 的空间分布。
BMC Neurosci. 2013 Dec 21;14:158. doi: 10.1186/1471-2202-14-158.
5
Mutant huntingtin gene-dose impacts on aggregate deposition, DARPP32 expression and neuroinflammation in HdhQ150 mice.突变亨廷顿基因剂量对 HdhQ150 小鼠聚集物沉积、DARPP32 表达和神经炎症的影响。
PLoS One. 2013 Sep 23;8(9):e75108. doi: 10.1371/journal.pone.0075108. eCollection 2013.
6
Tissue transglutaminase overexpression does not modify the disease phenotype of the R6/2 mouse model of Huntington's disease.组织转谷氨酰胺酶过表达不会改变亨廷顿病 R6/2 小鼠模型的疾病表型。
Exp Neurol. 2012 Sep;237(1):78-89. doi: 10.1016/j.expneurol.2012.05.015. Epub 2012 Jun 12.
7
A critical window of CAG repeat-length correlates with phenotype severity in the R6/2 mouse model of Huntington's disease.CAG 重复长度的关键窗口与亨廷顿病 R6/2 小鼠模型的表型严重程度相关。
J Neurophysiol. 2012 Jan;107(2):677-91. doi: 10.1152/jn.00762.2011. Epub 2011 Nov 9.
8
Genetics and neuropathology of Huntington's disease.亨廷顿病的遗传学和神经病理学。
Int Rev Neurobiol. 2011;98:325-72. doi: 10.1016/B978-0-12-381328-2.00014-6.
9
What have we learned from gene expression profiles in Huntington's disease?从亨廷顿病的基因表达谱中我们了解到了什么?
Neurobiol Dis. 2012 Jan;45(1):83-98. doi: 10.1016/j.nbd.2011.07.001. Epub 2011 Jul 12.
10
Prospects for cannabinoid therapies in basal ganglia disorders.大麻素疗法在基底神经节疾病中的前景。
Br J Pharmacol. 2011 Aug;163(7):1365-78. doi: 10.1111/j.1476-5381.2011.01365.x.